These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 6758687)

  • 1. Outer membrane permeation of beta-lactam antibiotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacae.
    Sawai T; Hiruma R; Kawana N; Kaneko M; Taniyasu F; Inami A
    Antimicrob Agents Chemother; 1982 Oct; 22(4):585-92. PubMed ID: 6758687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of labeled lipoprotein from Escherichia coli and Proteus mirabilis after incubation with [14C]penicillin.
    Gruner G; Tadros MH; Plapp R
    Z Naturforsch C Biosci; 1985; 40(5-6):415-20. PubMed ID: 3895763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in pathway of Escherichia coli outer membrane permeation between penicillins and cephalosporins.
    Yamaguchi A; Tomiyama N; Hiruma R; Sawai T
    FEBS Lett; 1985 Feb; 181(1):143-8. PubMed ID: 3882453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of porin proteins OmpF and OmpC in the permeation of beta-lactams.
    Jaffe A; Chabbert YA; Semonin O
    Antimicrob Agents Chemother; 1982 Dec; 22(6):942-8. PubMed ID: 6760806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Labelling of penicillin-binding proteins from Escherichia coli with photoreactive derivatives of beta-lactam antibiotics.
    Arán V; Rodríguez-Tébar A; Vázquez D
    FEBS Lett; 1983 Mar; 153(2):431-7. PubMed ID: 6352330
    [No Abstract]   [Full Text] [Related]  

  • 6. Differences between ceftizoxime and its stereoisomer in antibacterial activity and affinity for penicillin-binding proteins.
    Shigi Y; Kojo H; Wakasugi M; Nishida M
    Antimicrob Agents Chemother; 1981 Mar; 19(3):393-6. PubMed ID: 7018389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penicillin-binding proteins and the mechanism of action of beta-lactam antibiotics.
    Waxman DJ; Strominger JL
    Annu Rev Biochem; 1983; 52():825-69. PubMed ID: 6351730
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of porins in outer membrane of Proteus, Morganella, and Providencia spp. and their role in outer membrane permeation of beta-lactams.
    Mitsuyama J; Hiruma R; Yamaguchi A; Sawai T
    Antimicrob Agents Chemother; 1987 Mar; 31(3):379-84. PubMed ID: 3034144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competition of beta-lactam antibiotics for the penicillin-binding proteins of Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella aerogenes, Proteus rettgeri, and Escherichia coli: comparison with antibacterial activity and effects upon bacterial morphology.
    Curtis NA; Orr D; Ross GW; Boulton MG
    Antimicrob Agents Chemother; 1979 Sep; 16(3):325-8. PubMed ID: 116592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiply resistant mutants of Enterobacter cloacae selected by beta-lactam antibiotics.
    Then RL; Angehrn P
    Antimicrob Agents Chemother; 1986 Nov; 30(5):684-8. PubMed ID: 3492174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murein synthesis and beta-lactam antibiotic susceptibility during rod-to-sphere transition in a pbpA(Ts) mutant of Escherichia coli.
    Botta GA; Buffa D
    Antimicrob Agents Chemother; 1981 May; 19(5):891-900. PubMed ID: 7027927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ways to overcome cephalosporinase-mediated beta-lactam resistance in Enterobacter cloacae.
    Then RL; Angehrn P
    Chemioterapia; 1985 Feb; 4(1):83-9. PubMed ID: 3872727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the bacteriolytic and biochemical properties of ceftiolene (42980RP).
    Williamson R; Gutmann L; Kitzis MD; Acar JF
    J Antimicrob Chemother; 1984 Dec; 14(6):581-93. PubMed ID: 6394571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins.
    Neuwirth C; Siébor E; Duez JM; Péchinot A; Kazmierczak A
    J Antimicrob Chemother; 1995 Aug; 36(2):335-42. PubMed ID: 8522463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penicillin-binding proteins and peptidoglycan peptide-interacting proteins.
    Rodríguez-Tébar A; Vázquez D
    Microbiol Sci; 1984 Dec; 1(9):211-4. PubMed ID: 6444131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why are carbapenems active against Enterobacter cloacae resistant to third generation cephalosporins?
    Pechère JC
    Scand J Infect Dis Suppl; 1991; 78():17-21. PubMed ID: 1658922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
    Tsuchiya K; Kondo M; Kida M; Nakao M; Iwahi T; Nishi T; Noji Y; Takeuchi M; Nozaki Y
    Antimicrob Agents Chemother; 1981 Jan; 19(1):56-65. PubMed ID: 6941742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of permeability barriers in resistance to beta-lactam antibiotics.
    Nikaido H
    Pharmacol Ther; 1985; 27(2):197-231. PubMed ID: 2412244
    [No Abstract]   [Full Text] [Related]  

  • 19. The membrane-interactive properties of the low-molecular-mass penicillin-binding proteins of Escherichia coli.
    Phoenix DA; Harris F
    Biochem Soc Trans; 1995 Nov; 23(4):976-80. PubMed ID: 8654878
    [No Abstract]   [Full Text] [Related]  

  • 20. Mode of action of beta-lactam antibiotics.
    Tipper DJ
    Pharmacol Ther; 1985; 27(1):1-35. PubMed ID: 3889939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.